The Horizon 2020 project Imptox, started in April 2021 and running for 4 years, aims to understand how micro- and nanoplastic particles (MNPs) impact human health.
In particular, given the significant challenge posed by the amount of plastic waste in the environment, Impotox Consortium will develop an analytical platform to investigate the effect and toxicity of micro- and nanoplastic particles (MNPs) combined with environmental contaminants on the risk of allergic disease in preclinical and clinical studies.
The multidisciplinary team, made of 12 partners led by the Faculty of Chemistry of the University of Belgrade (HFUB), has expertise in a wide range of fields including food sciences & technology, allergy, immunology, biomedicine, biology, chemistry, bioinformatics, machine learning, pediatrics and others and is cooperating across Europe to investigate the relationship among micro- and nanoplastics (MNPs) and allergic diseases.
Moreover, Imptox is one of five projects in the EU Horizon 2020 programme that will work together with the European Commission’s Joint Research Center to form The European Research Cluster to Understand the Health Impacts of Micro- and Nanoplastics, CUSP. It is the cluster’s overall goal to contribute with new scientific knowledge and know-how to the European Strategy for Plastics.
Moverim supports the project taking part in WP2 on Dissemination, Communication and Exploitation.